{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:31:18Z","timestamp":1791203478359,"version":"4.2.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T00:00:00Z","timestamp":1154995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2007,1,22]]},"DOI":"10.1007\/s11010-006-9280-x","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T13:51:55Z","timestamp":1154958715000},"page":"113-120","source":"Crossref","is-referenced-by-count":126,"title":["Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells"],"prefix":"10.1007","volume":"295","author":[{"given":"Nambi","family":"Aiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Disa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Nerurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin H.","family":"Macphee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,8]]},"reference":[{"key":"9280_CR1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198901053200122","volume":"320","author":"D Steinberg","year":"1989","unstructured":"Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogeneicity. New Engl J Med 320: 915\u2013924","journal-title":"New Engl J Med"},{"key":"9280_CR2","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1073\/pnas.82.9.3000","volume":"82","author":"S Parthasarathy","year":"1985","unstructured":"Parthasarathy S, Steinbrecher UP, Barnett J, Witztum JL, Steinberg D. (1985) Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82: 3000\u20133004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"9280_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1042\/bst0290358","volume":"29","author":"IS Young","year":"2001","unstructured":"Young IS, McEneny J (2001) Lipoprotein oxidation atherosclerosis. Biochem Soc Trans 29(Pt 2): 358\u2013362","journal-title":"Biochem Soc Trans"},{"key":"9280_CR4","first-page":"31","volume":"63","author":"NV Prokazova","year":"1995","unstructured":"Prokazova NV, Zvezdina ND, Korotaeva AA. (1995) Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Mosc) 63: 31\u201337","journal-title":"Biochemistry (Mosc)"},{"key":"9280_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(94)05400-D","volume":"112","author":"Y Chen","year":"1995","unstructured":"Chen Y, Jiang B, Chen S, Yasuda O, Hirotani A, Ogihara T. (1995) Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112: 69\u201376","journal-title":"Atherosclerosis"},{"key":"9280_CR6","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.271.30.17791","volume":"271","author":"Y-C Chai","year":"1996","unstructured":"Chai Y-C, Howe PH, Di Corleto PE, Chisolm GM. (1996) Oxidized low density lipoprotein and lysophosphatidyl choline stimulate cell cycle entry in vascular smooth muscle cells. J Biol Chem 271: 17791\u201317797","journal-title":"J Biol Chem"},{"key":"9280_CR7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.ATV.16.2.194","volume":"16","author":"A Stiko","year":"1996","unstructured":"Stiko A, Regnstrom J, Shah PK, Cercek B, Nilsson J. (1996) Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol 16:194\u2013200","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9280_CR8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI115932","volume":"90","author":"N Kume","year":"1992","unstructured":"Kume N, Cybulsky MI, Gimborne MJ. (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138\u20131144","journal-title":"J Clin Invest"},{"key":"9280_CR9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI117047","volume":"93","author":"N Kume","year":"1994","unstructured":"Kume N, Gimborne MJ. (1994) Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93: 907\u2013911","journal-title":"J Clin Invest"},{"key":"9280_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0026-0495(96)90024-4","volume":"45","author":"N Takahara","year":"1996","unstructured":"Takahara N, Kashiwagi A, Maegawa H, Shigeta Y. (1996) Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45: 559\u2013564","journal-title":"Metabolism"},{"key":"9280_CR11","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1074\/jbc.273.12.6830","volume":"273","author":"JT Wong","year":"1998","unstructured":"Wong JT, Tran K, Pierce GN, Chan AC, Karmin O, Choy PC (1998) Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J Biol Chem 273: 6830\u20136836","journal-title":"J Biol Chem"},{"key":"9280_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9150(98)00288-3","volume":"143","author":"K Kugiyama","year":"1999","unstructured":"Kugiyama K, Sugiyama S, Ogata N, Oka H, Doi H, Ota Y, Yasue H. (1999) Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143: 201\u2013204","journal-title":"Atherosclerosis"},{"key":"9280_CR13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0891-5849(00)00227-6","volume":"28","author":"GM3rd Chisolm","year":"2000","unstructured":"Chisolm GM3rd, Chai Y. (2000) Regulation of cell growth by oxidized LDL. Free Radic Biol Med 28: 1697\u20131707","journal-title":"Free Radic Biol Med"},{"key":"9280_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1054-8807(03)00072-3","volume":"12","author":"BC Dickson","year":"2003","unstructured":"Dickson BC, Gotlieb AI. (2003) Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc Path 12: 237\u2013248","journal-title":"Cardiovasc Path"},{"issue":"10","key":"9280_CR15","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.0000035408.93749.71","volume":"22","author":"JX Rong","year":"2002","unstructured":"Rong JX, Berman JW, Taubman MB, Fisher EA. (2002) Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 22(10): 1617\u20131623","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9280_CR16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","volume":"86","author":"W Palinski","year":"1989","unstructured":"Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86: 1372\u20131376","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9280_CR17","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0022-2275(20)34898-7","volume":"40","author":"LS Golfman","year":"1999","unstructured":"Golfman LS, Haughey NJ, Wong JT, Jiang JY, Lee D, Geiger JD, Choy PC (1999) Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells J Lipid Res 40: 1818\u20131826","journal-title":"J Lipid Res"},{"key":"9280_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1350-9462(93)E0005-O","volume":"14","author":"AA Abdel-Latif","year":"1995","unstructured":"Abdel-Latif AA. (1995) Phosphoinositides and arachidonic acid signaling systems in the mammalian iris. Prog Retin Eye Res 14: 75\u2013107","journal-title":"Prog Retin Eye Res"},{"key":"9280_CR19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.ATV.0000133606.69732.4c","volume":"24","author":"R Natarajan","year":"2004","unstructured":"Natarajan R, Nadler JL. (2004) Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24: 1542\u20131548","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9280_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/o03-080","volume":"82","author":"CC Leslie","year":"2004","unstructured":"Leslie CC. (2004) Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol 82: 1\u201317","journal-title":"Biochem Cell Biol"},{"key":"9280_CR21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00041433-200310000-00005","volume":"14","author":"M Mehrabian","year":"2003","unstructured":"Mehrabian M, Allayee H. (2003) 5-lipoxygenase and atherosclerosis. Curr Opin Lipidol 14: 447\u2013457","journal-title":"Curr Opin Lipidol"},{"key":"9280_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/hq0302.105593","volume":"22","author":"RJ Aiello","year":"2002","unstructured":"Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. (2002) Leukotriene B4 receptor antagonists reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 22: 443\u2013449","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9280_CR23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.ATV.0000110503.16605.15","volume":"24","author":"K Subbarao","year":"2004","unstructured":"Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B. (2004) Role of leukotriene B4 receptors in the development of atherosclerosis: Potential Mechanisms. Arterioscler Thromb Vasc Biol 24: 369\u2013375","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9280_CR24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI118211","volume":"96","author":"A Zembowicz","year":"1995","unstructured":"Zembowicz A, Jones SL, Wu KK. (1995) Induction of cyclooxygensase-2 in human umbilical cells by lysophosphatidylcholine. J Clin Invest 96: 1688\u20131692","journal-title":"J Clin Invest"},{"key":"9280_CR25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.2001.4510","volume":"281","author":"Y Rikitake","year":"2001","unstructured":"Rikitake Y, Hirata K, Kawashima S, Takeuchi S, Shimokawa Y, Kojima Y, Inoue N, Yokoyama M. (2001) Signaling Mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem Biophys Res Comm 281: 1291\u20131297","journal-title":"Biochem Biophys Res Comm"},{"key":"9280_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"JR Vane","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38: 97\u2013120","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9280_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2003.12.003","volume":"4","author":"MF Linton","year":"2004","unstructured":"Linton MF, Fazio S. (2004) Cyclooxygenase-2 and inflammation in atherosclerosis. Curr Opin Pharmacol 4: 116\u2013123","journal-title":"Curr Opin Pharmacol"},{"key":"9280_CR28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.RES.83.5.508","volume":"83","author":"E Nishi","year":"1998","unstructured":"Nishi E, Kume N, Ueno Y, Ochi H, Moriwaki H, Kita T. (1998) Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. Cir Res 83: 508\u2013515","journal-title":"Cir Res"},{"key":"9280_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0021-9150(97)00295-5","volume":"137","author":"Y Liu-Wu","year":"1998","unstructured":"Liu-Wu Y, Hurt-Camejo E, Wiklund O. (1998) Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis 137: 351\u2013357","journal-title":"Atherosclerosis"},{"key":"9280_CR30","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1210\/endo.137.10.8828503","volume":"137","author":"BL Spangelo","year":"1996","unstructured":"Spangelo BL, Jarvis D (1996) Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro Endocrinology 137: 4419\u20134426","journal-title":"Endocrinology"},{"key":"9280_CR31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0026-0495(96)90024-4","volume":"45","author":"N Takahara","year":"1996","unstructured":"Takahara N, Kashiwagi A, Maegawa H, Shigeta Y (1996) Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45: 559\u2013564","journal-title":"Metabolism"},{"key":"9280_CR32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.0000035408.93749.71","volume":"22","author":"JX Rong","year":"2002","unstructured":"Rong JX, Berman JW, Taubman MB, Fisher EA (2002) Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler Thromb Vas Biol 22: 1617\u20131623","journal-title":"Arterioscler Thromb Vas Biol"},{"issue":"2","key":"9280_CR33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","volume":"127","author":"HG Rus","year":"1996","unstructured":"Rus HG,Vlaicu R, Niculescu F (1996) Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127(2): 263\u2013271","journal-title":"Atherosclerosis"},{"key":"9280_CR34","first-page":"585","volume-title":"Atherosclerosis and coronary artery disease","author":"P Libby","year":"1996","unstructured":"Libby P, Ross R (1996) Cytokines and growth regulatory molecules In: Fuster V, Ross R, Topol EJ (eds), Atherosclerosis and coronary artery disease Vol 1. Philadelphia Lippincott-Raven 585\u2013594"},{"key":"9280_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tcm.2004.04.003","volume":"14","author":"L Zhao","year":"2004","unstructured":"Zhao L, Funk CD. (2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 14: 191\u2013195","journal-title":"Trends Cardiovasc Med"},{"key":"9280_CR36","first-page":"11","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET. (2004) CRP as a Mediator of Disease, Circulation 109: 11\u201314","journal-title":"Circulation"},{"key":"9280_CR37","doi-asserted-by":"crossref","first-page":"H1713","DOI":"10.1152\/ajpheart.1991.260.5.H1713","volume":"260","author":"U Ikeda","year":"1991","unstructured":"Ikeda U, Ikeda M, Oohara T, Oguchi T, Kamitani Y, Kane S. (1991) Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol Heart Circ Physiol 260: H1713-H1717","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-006-9280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-006-9280-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-006-9280-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T05:17:06Z","timestamp":1627708626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-006-9280-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,8]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,1,22]]}},"alternative-id":["9280"],"URL":"https:\/\/doi.org\/10.1007\/s11010-006-9280-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,8]]}}}